drugset / Trial / NCT03388151

Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy

NCT03388151

Phase 3 Unknown 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy

Timeline

Start
2016-04-01
Primary completion
2022-11-11
Completion
2022-12-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 3 mg Intravenous
Comparator Propofol Small molecule 1 mg/kg Intravenous

Indications